作者
Eunkyeong Jung, Chenkai Mao, Misha Bhatia, Edward C Koellhoffer, Steven N Fiering, Nicole F Steinmetz
发表日期
2022/11/18
期刊
Molecular pharmaceutics
卷号
20
期号
1
页码范围
500-507
出版商
American Chemical Society
简介
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic, and durable efficacy. While CPMV is not infectious to mammals, it is infectious to legumes; therefore, agronomic safety needs to be addressed to broaden the translational application of CPMV. RNA-containing formulations are preferred over RNA-free virus-like particles because the RNA and protein, each, contribute to CPMV’s potent antitumor efficacy. We have previously optimized inactivation methods to develop CPMV that contains RNA but is not infectious to plants. We established that inactivated CPMV has reduced efficacy compared to untreated, native CPMV. However, a systematic comparison between native CPMV and different inactivated forms of CPMV was not done. Therefore, in this study, we directly compared the …
引用总数
学术搜索中的文章